World’s first baby born by IVF done almost entirely by a machine

Could Automated IVF Procedures Reduce Human Error and Increase Success Rates?

A groundbreaking form of in vitro fertilisation (IVF) has recently resulted in a successful birth, sparking optimism about the potential to reduce the risk of errors in such procedures. The innovative approach involves automation, aiming to enhance precision and efficiency during IVF treatments.

One common IVF technique, known as intracytoplasmic sperm injection (ICSI), involves the direct injection of sperm into eggs within a laboratory setting. This method is often preferred in cases of male infertility, as it bypasses the need for sperm to reach the egg naturally. Subsequently, resulting embryos are implanted into the uterus. Alternatively, traditional IVF involves combining sperm and eggs in a dish and waiting for fertilisation to occur, although this method is generally less successful and requires less intervention.

Despite its advantages, ICSI can be prone to human error due to the intricate and judgment-intensive nature of the procedure. According to Jacques Cohen, a researcher at Conceivable Life Sciences in New York City, medical professionals overseeing ICSI may experience fatigue and distractions, leading to errors that can impact fertilisation success rates and birth outcomes.

To address this challenge, Cohen and his team have developed a sophisticated machine capable of executing 23 essential steps in the ICSI process. Each step is initiated by an operator via a live video stream, allowing for remote supervision even from different geographical locations.

Noteworthy features of the automated system include the use of artificial intelligence to identify and select the healthiest sperm cells for fertilisation based on their visual characteristics. Additionally, the machine employs laser technology to immobilise sperm by targeting their tails, simplifying the process of sperm extraction and injection into eggs. While similar approaches have been explored previously, with documented instances of successful live births, the novelty of this system lies in its comprehensive automation of key ICSI steps.

In a recent trial, the automated system was tested on a couple facing fertility challenges, including male infertility and egg production issues. The results indicated that the automated process generated four embryos from donor eggs, outperforming the manual ICSI method in terms of embryo formation. Subsequent selection of the top two embryos using AI-based chromosome analysis led to a successful pregnancy and birth.

Although this initial success is promising, Joyce Harper, a fertility expert at University College London, emphasizes the need for larger studies to compare the effectiveness of automated versus manual ICSI procedures in terms of birth rates. While automated IVF may initially pose financial constraints due to additional expenses, Cohen remains optimistic about cost reductions over time through system optimization and standardization.

Overall, the advent of automated IVF represents a significant advancement in reproductive technology, offering a glimpse into a future where precision and efficiency converge to enhance fertility treatments and improve outcomes for aspiring parents.